Moderna (NASDAQ: MRNA) held its R&D Day on September 12, with the company providing key updates on its strategic and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE